Fractyl Health (GUTS) Competitors $1.79 -0.03 (-1.65%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GUTS vs. DCTH, ZIMV, NPCE, RCEL, CVRX, SMTI, ZYXI, LUNG, ELMD, and CATXShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Delcath Systems (DCTH), ZimVie (ZIMV), NeuroPace (NPCE), AVITA Medical (RCEL), CVRx (CVRX), Sanara MedTech (SMTI), Zynex (ZYXI), Pulmonx (LUNG), Electromed (ELMD), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Delcath Systems ZimVie NeuroPace AVITA Medical CVRx Sanara MedTech Zynex Pulmonx Electromed Perspective Therapeutics Delcath Systems (NASDAQ:DCTH) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Do analysts prefer DCTH or GUTS? Delcath Systems currently has a consensus price target of $21.50, suggesting a potential upside of 95.28%. Fractyl Health has a consensus price target of $22.00, suggesting a potential upside of 1,129.05%. Given Fractyl Health's higher possible upside, analysts clearly believe Fractyl Health is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DCTH or GUTS more profitable? Delcath Systems has a net margin of -150.70% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-150.70% -338.16% -104.02% Fractyl Health -64,849.48%N/A -57.21% Do institutionals & insiders hold more shares of DCTH or GUTS? 61.1% of Delcath Systems shares are held by institutional investors. 17.9% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer DCTH or GUTS? Delcath Systems received 27 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 25.64% of users gave Delcath Systems an outperform vote. CompanyUnderperformOutperformDelcath SystemsOutperform Votes3025.64% Underperform Votes8774.36% Fractyl HealthOutperform Votes3100.00% Underperform VotesNo Votes Does the media prefer DCTH or GUTS? In the previous week, Fractyl Health had 1 more articles in the media than Delcath Systems. MarketBeat recorded 1 mentions for Fractyl Health and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.76 beat Fractyl Health's score of 0.00 indicating that Delcath Systems is being referred to more favorably in the media. Company Overall Sentiment Delcath Systems Positive Fractyl Health Neutral Which has preferable valuation and earnings, DCTH or GUTS? Delcath Systems has higher revenue and earnings than Fractyl Health. Delcath Systems is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$22.64M15.55-$47.68M-$1.35-8.16Fractyl Health$97K887.60-$77.09M-$12.19-0.15 SummaryDelcath Systems beats Fractyl Health on 9 of the 16 factors compared between the two stocks. Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.Take these 4 steps today to protect your retirement NOW Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.10M$4.34B$5.13B$9.07BDividend YieldN/A44.57%5.08%4.23%P/E Ratio-0.1525.3789.5817.17Price / Sales887.6045.951,116.12116.95Price / CashN/A43.4542.8237.86Price / BookN/A7.094.774.78Net Income-$77.09M$13.64M$120.15M$225.60M7 Day Performance-12.25%-2.93%-1.92%-1.23%1 Month Performance-13.11%0.28%11.47%3.36%1 Year PerformanceN/A40.76%30.54%16.60% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health0.8828 of 5 stars$1.79-1.6%$22.00+1,129.1%N/A$86.10M$97,000.00-0.15102DCTHDelcath Systems2.8196 of 5 stars$12.43+2.6%$21.50+73.0%+212.8%$397.44M$22.64M-9.6776Gap DownHigh Trading VolumeZIMVZimVie2.3679 of 5 stars$13.82+0.7%$18.33+32.7%-20.6%$381.43M$457.43M-1.052,600NPCENeuroPace3.7644 of 5 stars$11.11+0.7%$14.60+31.4%+24.4%$331.61M$76.45M-11.03170Analyst ForecastPositive NewsRCELAVITA Medical1.6504 of 5 stars$12.53+2.6%$16.50+31.7%-5.3%$328.54M$50.14M-5.48130News CoveragePositive NewsCVRXCVRx3.7816 of 5 stars$13.41+4.5%$16.67+24.3%-49.2%$325.38M$47.26M-4.75200Positive NewsSMTISanara MedTech1.9969 of 5 stars$33.76-2.6%$44.00+30.3%-14.5%$295.06M$64.99M-35.0060ZYXIZynex3.4977 of 5 stars$8.46+3.9%$14.00+65.5%-21.1%$269.45M$184.32M54.271,100Positive NewsLUNGPulmonx2.6794 of 5 stars$6.14+0.7%$12.75+107.7%-49.2%$242.46M$79.30M-4.15250ELMDElectromedN/A$28.35+0.6%N/A+158.0%$239.78M$57.06M39.14174CATXPerspective Therapeutics3.3599 of 5 stars$3.43-1.4%$15.14+341.5%N/A$231.83M$1.43M0.00116Positive News Related Companies and Tools Related Companies Delcath Systems Alternatives ZimVie Alternatives NeuroPace Alternatives AVITA Medical Alternatives CVRx Alternatives Sanara MedTech Alternatives Zynex Alternatives Pulmonx Alternatives Electromed Alternatives Perspective Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GUTS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.